null

SMILES: COc1ccc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)cc1

InChI Key: InChIKey=PIFZJZZTAILNFU-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454178   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454178 (US10717708, Example 17 | US11186544, Example 17) Show SMILES COc1ccc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)cc1 Show InChI InChI=1S/C26H26FN3O5S/c1-35-19-12-10-18(11-13-19)28-26(32)29-22-7-5-15-30(25(22)31)23-14-9-17(16-21(23)27)20-6-3-4-8-24(20)36(2,33)34/h3-4,6,8-14,16,22H,5,7,15H2,1-2H3,(H2,28,29,32)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	10	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454178 (US10717708, Example 17 | US11186544, Example 17) Show SMILES COc1ccc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)cc1 Show InChI InChI=1S/C26H26FN3O5S/c1-35-19-12-10-18(11-13-19)28-26(32)29-22-7-5-15-30(25(22)31)23-14-9-17(16-21(23)27)20-6-3-4-8-24(20)36(2,33)34/h3-4,6,8-14,16,22H,5,7,15H2,1-2H3,(H2,28,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	170	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454178 (US10717708, Example 17 | US11186544, Example 17) Show SMILES COc1ccc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)cc1 Show InChI InChI=1S/C26H26FN3O5S/c1-35-19-12-10-18(11-13-19)28-26(32)29-22-7-5-15-30(25(22)31)23-14-9-17(16-21(23)27)20-6-3-4-8-24(20)36(2,33)34/h3-4,6,8-14,16,22H,5,7,15H2,1-2H3,(H2,28,29,32)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	10	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454178 (US10717708, Example 17 | US11186544, Example 17) Show SMILES COc1ccc(NC(=O)NC2CCCN(C2=O)c2ccc(cc2F)-c2ccccc2S(C)(=O)=O)cc1 Show InChI InChI=1S/C26H26FN3O5S/c1-35-19-12-10-18(11-13-19)28-26(32)29-22-7-5-15-30(25(22)31)23-14-9-17(16-21(23)27)20-6-3-4-8-24(20)36(2,33)34/h3-4,6,8-14,16,22H,5,7,15H2,1-2H3,(H2,28,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	170	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair